Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Cadence Pharmaceuticals, Inc.    QEW   US12738T1007

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on CADENCE PHARMACEUTICALS, I
05/08 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals To Present At Three Inve..
05/02 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Reports First Quarter 20..
04/25 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals To Host Conference Call ..
03/12 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Announces the Availabili..
03/07 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Reports Fourth Quarter a..
03/04CADENCE PHARMACEUTICALS, INC.: quaterly earnings release
02/28 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals To Host Conference Call ..
02/26 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals' CEO Ted Schroeder To Pr..
02/06 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals' CEO Ted Schroeder To Pr..
01/23 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Estimates Fourth Quarter..
2012DJMedicines Agrees to Buy Incline; Reaches Collaboration Deal With Bristol-Myer..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals to Host Analyst and Inve..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals' CEO Ted Schroeder To Pr..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Reports Third Quarter 20..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals To Host Conference Call ..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals' CEO Ted Schroeder To Pr..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals To Present At The Wedbus..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Reports Second Quarter 2..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals To Host Conference Call ..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals To Present At The 7th An..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals' CEO Ted Schroeder To Pr..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Reports First Quarter 20..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals To Present At The Deutsc..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals to Host Conference Call ..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Reports Fourth Quarter a..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals to Host Conference Call ..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals' CEO Ted Schroeder to Pr..
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals CEO Ted Schroeder to Pre..
2012DJTHE COCA-COLA COMPANY: Us stock futures : hot stocks to watch
2012DJBRE PROPERTIES, INC.: Us stock futures : hot stocks to watch
2012 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Announces Voluntary Reca..
2011 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Announces Completion of ..
2011 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Announces Pricing of Pub..
2011 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Announces Proposed Publi..
2011 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals Reports Third Quarter 20..
2011 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals' CEO Ted Schroeder to Pr..
2011 CADENCE PHARMACEUTICALS, INC.: Cadence Pharmaceuticals to Host Conference Call ..
2011 CADENCE P: Cadence Pharmaceuticals to Present at Three Investment Conferences D..
2011 CADENCE P: Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Result..
2011 CADENCE P: Cadence Pharmaceuticals to Present at Two Investment Conferences Dur..
2011 CADENCE P: Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendation..
2011 CADENCE P: Cadence Pharmaceuticals to Host Conference Call and Webcast to Discu..
2011 CADENCE P: Cadence Pharmaceuticals Announces Addition of OFIRMEV® (acetaminophe..
2011 CADENCE P: Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Jefferi..
2011 CADENCE P: Cadence Pharmaceuticals Reports First Quarter 2011 Financial Results
2011 CADENCE P: Cadence Pharmaceuticals to Host Conference Call and Webcast to Discu..
2011 CADENCE P: Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Inves..
2011 CADENCE P: Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Fi..
2011 CADENCE P: Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Cowen a..
2011 CADENCE P: Cadence Pharmaceuticals to Host Conference Call and Webcast to Discu..
2011 CADENCE P: Cadence Pharmaceuticals to Present at Two Investment Conferences in ..
2011 CADENCE P: Cadence Pharmaceuticals Announces U.S. Launch and Availability of OF..
2010 CADENCE P: Cadence Pharmaceuticals Announces Partial Exercise of Over-Allotment..
2010 CADENCE P: Cadence Pharmaceuticals Announces Pricing of Public Offering of Comm..
2010 CADENCE P: Cadence Pharmaceuticals Announces Proposed Public Offering of Common..
2010 CADENCE P: Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
2010 CADENCE P: Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV(TM) (aceta..
2010 CADENCE P: Cadence Pharmaceuticals to Host Conference Call and Webcast to Discu..
2010 CADENCE P: Cadence Pharmaceuticals to Present at Four Investment Conferences Du..
2010 CADENCE P: Cadence Pharmaceuticals Reports Second Quarter 2010 Financial Result..
2010 CADENCE P: Cadence Pharmaceuticals to Host Conference Call and Webcast to Discu..
2010 CADENCE P: Cadence Pharmaceuticals to Present at Three Investment Conferences D..
2010 CADENCE P: Cadence Pharmaceuticals Signs Option Agreement to Acquire Incline Th..
2010 CADENCE P: Cadence Pharmaceuticals Announces OFIRMEV(TM) NDA Action Date of Nov..
2010 CADENCE P: Cadence Pharmaceuticals Reports First Quarter 2010 Financial Results
2010 CADENCE P: Cadence Pharmaceuticals Resubmits New Drug Application for OFIRMEV
2010 CADENCE P: Cadence Pharmaceuticals to Host Conference Call and Webcast to Discu..
2010 CADENCE P: Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Inves..
2010 CADENCE P: Cadence Pharmaceuticals Announces Plan to Resubmit NDA for OFIRMEV(T..
2010 CADENCE P: Cadence Pharmaceuticals Appoints Michael L. Eagle to its Board of Di..
2010 CADENCE P: Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Fi..
2010 CADENCE P: Cadence Pharmaceuticals to Host Conference Call and Webcast to Discu..
2010 CADENCE P: Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Cowen a..
2010 CADENCE P: Cadence Pharmaceuticals Receives Complete Response Letter from FDA f..
2009 CADENCE P: Cadence Pharmaceuticals Announces FDA Extends New Drug Application R..
1  2Next
Advertisement
Chart
Duration : Period :
Cadence Pharmaceuticals, I Technical Analysis Chart | QEW | US12738T1007 | 4-Traders
Income Statement Evolution
Cadence Pharmaceuticals, I : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.